199 related articles for article (PubMed ID: 18424460)
1. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats.
Nielsen FT; Jensen BL; Marcussen N; Skøtt O; Bie P
Nephrol Dial Transplant; 2008 Sep; 23(9):2777-83. PubMed ID: 18424460
[TBL] [Abstract][Full Text] [Related]
2. The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicity.
Nielsen FT; Jensen BL; Hansen PB; Marcussen N; Bie P
BMC Nephrol; 2013 Feb; 14():42. PubMed ID: 23425330
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Sun QL; Li M; Rui HL; Chen YP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
[TBL] [Abstract][Full Text] [Related]
6. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity.
Pérez-Rojas JM; Derive S; Blanco JA; Cruz C; Martínez de la Maza L; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1020-30. PubMed ID: 15998842
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
[TBL] [Abstract][Full Text] [Related]
8. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonists attenuate exaggerated exercise pressor reflex responses in hypertensive rats.
Downey RM; Mizuno M; Mitchell JH; Vongpatanasin W; Smith SA
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H788-H794. PubMed ID: 28733447
[TBL] [Abstract][Full Text] [Related]
11. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
Rahmouni K; Barthelmebs M; Imbs JL; De Jong W
Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1009-12. PubMed ID: 9749155
[TBL] [Abstract][Full Text] [Related]
12. Effects of eplerenone on heart and kidney in two-kidney, one-clip rats.
Hao L; Kanno Y; Fukushima R; Watanabe Y; Ishida Y; Suzuki H
Am J Nephrol; 2004; 24(1):54-60. PubMed ID: 14707436
[TBL] [Abstract][Full Text] [Related]
13. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
Rahmouni K; Barthelmebs M; Grima M; Imbs JL; Wybren De Jong
Hypertension; 1999 May; 33(5):1201-6. PubMed ID: 10334812
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
[TBL] [Abstract][Full Text] [Related]
15. Antagonist capacity of felodipine on cyclosporin A nephrotoxicity in the rat.
Dieperink H; Hansen HV; Kemp M; Leyssac PP; Starklint H; Kemp E
Nephrol Dial Transplant; 1992; 7(11):1124-9. PubMed ID: 1336140
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
[TBL] [Abstract][Full Text] [Related]
17. Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.
Alves SA; Carlos CP; Mendes GE; Oliveira SM; Luz MA; Souza RP; Matimoto RL; Coimbra TM; Burdmann EA
Am J Nephrol; 2012; 36(4):334-41. PubMed ID: 23018139
[TBL] [Abstract][Full Text] [Related]
18. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
Nakano M; Hirooka Y; Matsukawa R; Ito K; Sunagawa K
Hypertens Res; 2013 Mar; 36(3):277-84. PubMed ID: 23096235
[TBL] [Abstract][Full Text] [Related]
20. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
Epstein M; Williams GH; Weinberger M; Lewin A; Krause S; Mukherjee R; Patni R; Beckerman B
Clin J Am Soc Nephrol; 2006 Sep; 1(5):940-51. PubMed ID: 17699311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
